Abstract

Aim: The main aim of our study was to compare the variation of Gamma Index (GI) in Pre-treatment Verification Procedure in Intensity Modulated Radiotherapy (IMRT) Plans with Varying Grid Sizes Using 2D Array Detectors. Choosing an optimum grid size plays a vital role for planning in radiotherapy cases especially while treating with IMRT. A minimal change of even 1 mm of grid size can result in large variation in treatment planning and is reflected in quality assurance results also. Methods and Material: We compared IMRT plans for a total of 12 patients. Out of these 12 patients 4 were head and neck, 4 were pelvic and 4 were brain patients respectively. For each patient three plans were generated with three different grid sizes. The plan acceptance criteria were 95% of PTV to receive at least 95% of prescribed dose and dose to 1% of PTV not to exceed 107% of prescribed dose. Dose for the organs at risk were respected as per the QUANTEC guidelines. After plan acceptance corresponding Pre-treatment Verification Procedure for IMRT was executed by PTW 729 array detector. The Gamma index (GI) results of each plan were recorded for the three different grid sizes. The passing criteria were kept to be 3% Dose Difference (DD) and 3 mm Distance to Agreement (DTA) for all cases. Results: We estimated the variations in GI quality assurance results for patients undergoing IMRT planning with varying grid sizes of 3 mm, 5 mm and 10 mm respectively. We also evaluated 2% DD and 2 mm DTA, 3% DD, 3 mm DTA and 5% DD, 5 mm DTA criteria for passing result. Stastical analysis: We have calculated the average and standard Deviations (Std. Dev.) for each passing criteria for 2% DD, 2 mm DTA, 3% DD, 3 mm DTA and 5% DD, 5 mm DTA for each IMRT plans with varying grid sizes. Conclusions: Though the present results suggest the gamma criteria of 5% DD and 5 mm DTA as the most suitable criteria for IMRT quality assurance. This gamma criterion of 5% DD and 5 mm DTA favourably exceeds 95% in each case and grid sizes but it is not recommended for strict verification procedure in Intensity Modulated Radiotherapy (IMRT). The criteria of 2% DD and 2 mm DTA, and 3% DD and 3 mm DTA gamma values show below 90% for 5 mm and 10 mm grid sizes but exceeds 95% for the 3 mm grid sizes. Hence 3 mm or less grid sizes should be routinely used in pre-treatment verification procedure IMRT plans using 2D Array Detectors.

Highlights

  • The advantages of intensity-modulated radiation therapy (IMRT) in the treatment of head-and-neck cancer (HNC) have been showed in a number of studies [1,2,3]

  • Though the present results suggest the gamma criteria of 5% Dose Difference (DD) and 5 mm distance to agreement (DTA) as the most suitable criteria for Intensity Modulated Radiotherapy (IMRT) quality assurance

  • This gamma criterion of 5% DD and 5 mm DTA favourably exceeds 95% in each case and grid sizes but it is not recommended for strict verification procedure in Intensity Modulated Radiotherapy (IMRT)

Read more

Summary

Introduction

The advantages of intensity-modulated radiation therapy (IMRT) in the treatment of head-and-neck cancer (HNC) have been showed in a number of studies [1,2,3]. It has been shown that IMRT reduces grade-3 xerostomia compared to threedimensional conformal radiotherapy (3D CRT) [4,5]. That is the reason; IMRT has become the standard treatment in many centers. The complexity of intensity-modulated radiotherapy (IMRT) demands thorough verification of planned radiation dose before treatment. The film dosimetry for pretreatment verification of patientspecific IMRT dose distribution is gradually being replaced by twodimensional (2D) detector arrays due to their ease of use and immediate readout of the results. For pretreatment verification of IMRT plans 2D detector arrays consisting of a large number of ionization chambers or diodes have been reported.

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call